Counter-regulatory 'Renin-Angiotensin' System-based Candidate Drugs to Treat COVID-19 Diseases in SARS-CoV-2-infected Patients

Infect Disord Drug Targets. 2020;20(4):407-408. doi: 10.2174/1871526520666200518073329.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antiviral Agents / pharmacology
  • Antiviral Agents / therapeutic use*
  • COVID-19
  • Coronavirus Infections / drug therapy*
  • Drug Delivery Systems
  • Humans
  • Pandemics
  • Pneumonia, Viral / drug therapy*
  • Renin-Angiotensin System / drug effects*

Substances

  • Antiviral Agents

Supplementary concepts

  • COVID-19 drug treatment